Search research articles
Contact Us
Filters
Showing results (1-10 of 107) with videos related to
Page
of 11
Sort By:
Ostomy/Wound Management
|
April 23, 2011
Conservative management of Achilles tendon wounds: results of a retrospective study
Yosef Kleinman, Avivit Cahn
Nature Reviews. Cardiology
|
March 11, 2016
Heart failure: SGLT2 inhibitors and heart failure -- clinical implications
Itamar Raz, Avivit Cahn
Heart Failure Clinics
|
October 10, 2022
SGLT2 Inhibitors and Safety in Older Patients
Rena Pollack, Avivit Cahn
The Lancet. Healthy Longevity
|
September 21, 2023
Prescription patterns in people who are frail
Isca Hershkowitz, Avivit Cahn
Expert Opinion on Emerging Drugs
|
June 4, 2013
Emerging gliptins for type 2 diabetes
Avivit Cahn, Itamar Raz
Diabetes Care
|
November 24, 2016
Comment on Shahraz et al. Do Patient Characteristics Impact Decisions by Clinicians on Hemoglobin A1c Targets? Diabetes Care 2016;38:e145-e146
Itamar Raz, Avivit Cahn
Diabetes Care
|
July 22, 2016
Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes
Avivit Cahn, William T Cefalu
Harefuah
|
October 24, 2021
[DIABETIC FOOT IN ISRAEL - CURRENT STATUS AND FUTURE PERSPECTIVES]
Avivit Cahn, Moshe Kulikovsky, Inbar Zucker
Journal of Diabetes
|
September 6, 2017
Digital health technology and diabetes management
Avivit Cahn, Amit Akirov, Itamar Raz
Reviews in Endocrine & Metabolic Disorders
|
April 24, 2016
Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes
Avivit Cahn, Simona Cernea, Itamar Raz
Page
of 11
Search research articles
Search
Showing results (1-10 of 107) with videos related to
Sort By:
Page
of 11
Ostomy/Wound Management
|
April 23, 2011
Conservative management of Achilles tendon wounds: results of a retrospective study
Yosef Kleinman, Avivit Cahn
Nature Reviews. Cardiology
|
March 11, 2016
Heart failure: SGLT2 inhibitors and heart failure -- clinical implications
Itamar Raz, Avivit Cahn
Heart Failure Clinics
|
October 10, 2022
SGLT2 Inhibitors and Safety in Older Patients
Rena Pollack, Avivit Cahn
The Lancet. Healthy Longevity
|
September 21, 2023
Prescription patterns in people who are frail
Isca Hershkowitz, Avivit Cahn
Expert Opinion on Emerging Drugs
|
June 4, 2013
Emerging gliptins for type 2 diabetes
Avivit Cahn, Itamar Raz
Diabetes Care
|
November 24, 2016
Comment on Shahraz et al. Do Patient Characteristics Impact Decisions by Clinicians on Hemoglobin A1c Targets? Diabetes Care 2016;38:e145-e146
Itamar Raz, Avivit Cahn
Diabetes Care
|
July 22, 2016
Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes
Avivit Cahn, William T Cefalu
Harefuah
|
October 24, 2021
[DIABETIC FOOT IN ISRAEL - CURRENT STATUS AND FUTURE PERSPECTIVES]
Avivit Cahn, Moshe Kulikovsky, Inbar Zucker
Journal of Diabetes
|
September 6, 2017
Digital health technology and diabetes management
Avivit Cahn, Amit Akirov, Itamar Raz
Reviews in Endocrine & Metabolic Disorders
|
April 24, 2016
Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes
Avivit Cahn, Simona Cernea, Itamar Raz
Page
of 11